Race is not an independent predictor of biochemical recurrence after radical prostatectomy in an equal access medical center

被引:61
作者
Freedland, SJ
Jalkut, M
Dorey, F
Sutter, ME
Aronson, WJ
机构
[1] Univ Calif Los Angeles, Sch Med, Dept Urol, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Sch Med, Dept Biostat, Los Angeles, CA 90095 USA
[3] Vet Affairs Med Ctr, Los Angeles, CA USA
[4] Vet Affairs Med Ctr, W Los Angeles, CA USA
[5] Vet Affairs Med Ctr, Sepulveda, CA USA
关键词
D O I
10.1016/S0090-4295(00)00587-2
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To compare the racial differences in clinical and pathologic features between black and white men who underwent radical prostatectomy (RP) in an equal access health care center and to determine whether race is an independent predictor of biochemical recurrence. Methods. A retrospective survey of 273 patients (125 black, 148 white) who underwent RP at the West Los Angeles Veterans Affairs Medical Center between 1991 and 1999 was undertaken. Patients were analyzed for racial differences in age at diagnosis, clinical stage, preoperative serum prostate-specific antigen (PSA), and Gleason score of the prostate biopsy specimens. Surgical specimens were studied to determine pathologic stage, Gleason score, incidence of seminal vesicle invasion, positive surgical margins, capsular penetration, and pelvic lymph node involvement. Patients were followed for PSA recurrence (greater than 0.2 ng/mL). Multivariate analysis was used to determine the clinical and pathologic variables that were significant in predicting biochemical recurrence after RP and to determine whether race was an independent predictor of biochemical failure. Results. No significant differences were found between black and white men in the preoperative factors (clinical stage, age at diagnosis, biopsy Gleason score, and serum PSA) or in the pathologic features of the RP specimens (Gleason score, pathologic stage, incidence of positive surgical margins, capsular penetration, seminal vesicle invasion, or lymph node involvement). In addition, no differences were found between black and white men in the PSA recurrence rates after RP using Kaplan-Meier survival curves (P = 0.651). Multivariate analysis revealed that serum PSA (P = 0.010), biopsy Gleason score (P = 0.003), younger age (P = 0.010), surgical Gleason score (P = 0.005), and lymph node involvement (P = 0.022) were all independent predictors of biochemical recurrence. Race was not a significant predictor of biochemical failure in multivariate analysis (P = 0.199). Conclusions. In an equal access medical care facility, no differences were evident between black and white men in the preoperative clinical factors or the pathologic features of the RP specimens. In addition, no differences were observed in the PSA recurrence rates after RP. Serum PSA, biopsy Gleason score, younger age, surgical Gleason score, and lymph node involvement were all independent predictors of biochemical recurrence. Race was not an independent predictor of biochemical recurrence. UROLOGY 56: 87-91, 2000. (C) 2000, Elsevier Science Inc.
引用
收藏
页码:87 / 91
页数:5
相关论文
共 31 条
[1]  
*AM JOINT COMM CAN, 1992, MAN STAG CANC
[2]   Population-based study of pelvic lymph node positivity in clinically localized prostate cancer: A study comparing African Americans and whites [J].
Barroso, U ;
Oskanian, P ;
Tefilli, MV ;
Banerjee, M ;
Grignon, D ;
Sakr, W ;
Pontes, JE ;
Powell, IJ .
UROLOGY, 1999, 53 (01) :187-191
[3]  
BRAWN PN, 1993, CANCER, V71, P2569, DOI 10.1002/1097-0142(19930415)71:8<2569::AID-CNCR2820710822>3.0.CO
[4]  
2-R
[5]   KNOWLEDGE, BELIEFS, AND PRIOR SCREENING BEHAVIOR AMONG BLACKS AND WHITES REPORTING FOR PROSTATE-CANCER SCREENING [J].
DEMARKWAHNEFRIED, W ;
STRIGO, T ;
CATOE, K ;
CONAWAY, M ;
BRUNETTI, M ;
RIMER, BK ;
ROBERTSON, CN .
UROLOGY, 1995, 46 (03) :346-351
[6]   Disease recurrence in black and white men undergoing radical prostatectomy for clinical stage T1-T2 prostate cancer [J].
Eastham, JA ;
Kattan, MW .
JOURNAL OF UROLOGY, 2000, 163 (01) :143-145
[7]   Race and cause specific survival with prostate cancer: Influence of clinical stage, Gleason score, age and treatment [J].
Fowler, JE ;
Bigler, SA ;
Bowman, G ;
Kilambi, NK .
JOURNAL OF UROLOGY, 2000, 163 (01) :137-142
[8]   Survival in blacks and whites after treatment for localized prostate cancer [J].
Fowler, JE ;
Terrell, F .
JOURNAL OF UROLOGY, 1996, 156 (01) :133-136
[9]   Clinical characteristics in black and white men with prostate cancer in an equal access medical center [J].
Freedland, SJ ;
Sutter, ME ;
Naitoh, J ;
Dorey, F ;
Csathy, GS ;
Aronson, WJ .
UROLOGY, 2000, 55 (03) :387-390
[10]  
GLEASON DONALD F., 1966, CANCER CHEMO THERAP REP, V50, P125